Login / Signup

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease.

Johannes StallhoferJan GuseMiriam KesselmeierPhilip Christian GrunertKathleen LangeRobert StalmannVerena EckardtAndreas Stallmach
Published in: International journal of colorectal disease (2023)
Immunogenic LOR to infliximab or adalimumab in IBD can be successfully reversed using immunomodulator comedication.
Keyphrases
  • rheumatoid arthritis
  • ulcerative colitis
  • stem cells
  • emergency department
  • mesenchymal stem cells
  • systemic lupus erythematosus
  • adverse drug
  • bone marrow